NO980275L - Double virus inactivated human blood plasma, blood plasma derivatives prepared therefrom and method for their preparation - Google Patents
Double virus inactivated human blood plasma, blood plasma derivatives prepared therefrom and method for their preparationInfo
- Publication number
- NO980275L NO980275L NO980275A NO980275A NO980275L NO 980275 L NO980275 L NO 980275L NO 980275 A NO980275 A NO 980275A NO 980275 A NO980275 A NO 980275A NO 980275 L NO980275 L NO 980275L
- Authority
- NO
- Norway
- Prior art keywords
- blood plasma
- preparation
- prepared therefrom
- derivatives prepared
- inactivated human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention concerns a method of producing a virally safe therapeutic biological preparation from human plasma using a detergent and retaining at least 50 % of the biological activity, the detergent being removed at the end of the method. Non-ionic surfactants, whose molecular structure comprises a hydrophobic part consisting of a linear aliphatic chain of between 8 and 10 carbon atoms, are used as detergents. The detergent treatment can be followed by a heat treatment, optionally using conventional stabilizers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19528221A DE19528221C2 (en) | 1995-08-01 | 1995-08-01 | Process for the production of a virus-safe, therapeutic preparation from human plasma |
PCT/EP1995/004309 WO1997004815A1 (en) | 1995-08-01 | 1995-11-03 | Doubly virus-inactivated human blood plasma, blood plasma derivatives produced therefrom and method for their production |
Publications (3)
Publication Number | Publication Date |
---|---|
NO980275L true NO980275L (en) | 1998-01-21 |
NO980275D0 NO980275D0 (en) | 1998-01-21 |
NO311662B1 NO311662B1 (en) | 2002-01-02 |
Family
ID=7768410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19980275A NO311662B1 (en) | 1995-08-01 | 1998-01-21 | Process for Preparing a Virus-Safe, Therapeutic Biological Preparation from Human Plasma Using Nonionic Surfactants |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0841954B1 (en) |
AT (1) | ATE183928T1 (en) |
AU (1) | AU3846595A (en) |
CA (1) | CA2228031A1 (en) |
DE (2) | DE19528221C2 (en) |
DK (1) | DK0841954T3 (en) |
ES (1) | ES2137544T3 (en) |
GR (1) | GR3031779T3 (en) |
NO (1) | NO311662B1 (en) |
WO (1) | WO1997004815A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632648B1 (en) * | 1996-05-14 | 2003-10-14 | Elan Drug Delivery Limited | Methods of terminal sterilization of fibrinogen |
AU2018331357A1 (en) | 2017-09-18 | 2020-04-02 | Bayer Healthcare Llc | Methods of inactivation of viruses using N-methylglucamides and its Derivatives |
KR20200100771A (en) | 2017-12-19 | 2020-08-26 | 체에스엘 베링 렝나우 아게 | Protein purification and virus inactivation by alkyl glycosides |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3173208D1 (en) * | 1980-10-06 | 1986-01-23 | Edward Shanbrom | Method of reducing undesirable activities of biological and pharmaceutical products |
US4481189A (en) * | 1982-04-14 | 1984-11-06 | New York Blood Center Inc. | Process for preparing sterilized plasma and plasma derivatives |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
FR2674536B1 (en) * | 1991-03-29 | 1994-10-21 | Fondation Nale Transfusion San | VIRUS INACTIVATION PROCESS AND PHARMACEUTICAL COMPOSITION FOR VIRUS INACTIVATION. |
AU6653094A (en) * | 1992-12-16 | 1994-07-04 | Immuno Aktiengesellschaft | Process for preparing a virus-safe biological composition |
DE4318435C2 (en) * | 1993-02-09 | 1997-01-23 | Octapharma Ag | Method for inactivating viruses that are not provided with lipid envelopes |
-
1995
- 1995-08-01 DE DE19528221A patent/DE19528221C2/en not_active Expired - Fee Related
- 1995-11-03 DK DK95936586T patent/DK0841954T3/en active
- 1995-11-03 ES ES95936586T patent/ES2137544T3/en not_active Expired - Lifetime
- 1995-11-03 CA CA002228031A patent/CA2228031A1/en not_active Abandoned
- 1995-11-03 WO PCT/EP1995/004309 patent/WO1997004815A1/en active IP Right Grant
- 1995-11-03 AT AT95936586T patent/ATE183928T1/en not_active IP Right Cessation
- 1995-11-03 DE DE59506747T patent/DE59506747D1/en not_active Expired - Fee Related
- 1995-11-03 EP EP95936586A patent/EP0841954B1/en not_active Expired - Lifetime
- 1995-11-03 AU AU38465/95A patent/AU3846595A/en not_active Abandoned
-
1998
- 1998-01-21 NO NO19980275A patent/NO311662B1/en not_active IP Right Cessation
-
1999
- 1999-11-08 GR GR990402871T patent/GR3031779T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE19528221C2 (en) | 1998-10-22 |
GR3031779T3 (en) | 2000-02-29 |
CA2228031A1 (en) | 1997-02-13 |
ATE183928T1 (en) | 1999-09-15 |
NO311662B1 (en) | 2002-01-02 |
AU3846595A (en) | 1997-02-26 |
EP0841954B1 (en) | 1999-09-01 |
DK0841954T3 (en) | 2000-03-27 |
DE19528221A1 (en) | 1997-02-06 |
WO1997004815A1 (en) | 1997-02-13 |
NO980275D0 (en) | 1998-01-21 |
ES2137544T3 (en) | 1999-12-16 |
DE59506747D1 (en) | 1999-10-07 |
EP0841954A1 (en) | 1998-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073151L (en) | Methods and compositions for treating hepatitis C virus | |
IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
AU3216695A (en) | Lipid analogs for treating viral infections | |
TW225532B (en) | ||
DK602988A (en) | NUCLEOSIDE DERIVATIVES WITH ANTIVIRAL EFFECT AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS | |
DK1390378T3 (en) | Pharmaceutically active uridine esters | |
ATE306938T1 (en) | USE OF CPG AS AN ADJUVANT FOR HIV VACCINE | |
HU901585D0 (en) | Method for treatment of viral infections using functional derivatives of icam-1 | |
ES2173923T3 (en) | PROCEDURE THAT ALLOWS TO INACTIVATE A VIRUS IN THE PRESENCE OF A POLIETER AND AN AGENT. | |
GR3022248T3 (en) | Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses | |
EA200100700A1 (en) | GENES AND PROTEINS AND THEIR APPLICATION | |
NO980275D0 (en) | Double virus inactivated human blood plasma, blood plasma derivatives prepared therefrom and method for their preparation | |
IT1312569B1 (en) | USE OF GSSG ENZYME REDUCTED FOR THERAPEUTIC TREATMENT AND LAPROPHYLAXIS OF HIV-INFECTED PATIENTS. | |
EA200100701A1 (en) | OUTER SURFACE PROTEINS, THEIR GENES AND THEIR APPLICATION | |
DK0538690T3 (en) | Arylquinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid derivatives, process for their preparation in drug use | |
EP0189587A3 (en) | Method of sterilizing recombinant microorganism | |
FI893346A0 (en) | ICKE-REVERTERANDE RNA VIRUS. | |
AU630249B2 (en) | Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones | |
WO1988008707A3 (en) | Rubradirin derivatives for treatment of hiv infection | |
LTIP1943A (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
UA29106A (en) | The method for treatment of vibration disease | |
MX9602981A (en) | Benzalkonium fluoride injectable solution. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN MAY 2003 |